Mostrar el registro sencillo del ítem

dc.contributor.authorFernández Díaz, Daniel
dc.contributor.authorRodriguez-Vidal, C.
dc.contributor.authorSilva Rodríguez, Paula
dc.contributor.authorPaniagua, L.
dc.contributor.authorBlanco-Teijeiro, M.J.
dc.contributor.authorPardo Pérez, María 
dc.contributor.authorPiñeiro Ces, Antonio 
dc.contributor.authorBande Rodriguez, Manuel Francisco 
dc.date.accessioned2025-08-26T09:28:53Z
dc.date.available2025-08-26T09:28:53Z
dc.date.issued2022
dc.identifier.citationFernandez-Diaz D, Rodriguez-Vidal C, Silva-Rodríguez P, Paniagua L, Blanco-Teijeiro MJ, Pardo M, et al. Applications of Non-Coding RNAs in Patients With Retinoblastoma. Frontiers in Genetics. Frontiers Media S.A.; 2022;13.
dc.identifier.issn1664-8021
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/63389a15250f6f2135360f2b*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20677
dc.description.abstractRetinoblastoma (RB) is the most common primary intraocular malignancy in childhood. In the carcinogenic process of neoplasms such as RB, the role of non-coding RNAs (ncRNAs) has been widely demonstrated recently. In this review, we aim to provide a clinical overview of the current knowledge regarding ncRNAs in relation to RB. Although ncRNAs are now considered as potential diagnostic biomarkers, prognostic factors, and therapeutic targets, further studies will facilitate enhanced understanding of ncRNAs in RB physiopathology and define the roles ncRNAs can play in clinical practice.en
dc.description.sponsorshipFunding This research was supported by Grant PI16/00143 from Instituto de Salud Carlos III.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleApplications of Non-Coding RNAs in Patients With Retinoblastoma*
dc.typeReviewen
dc.authorsophosFernandez-Diaz, M. D.
dc.authorsophosRodriguez-Vidal, C.
dc.authorsophosSilva-Rodríguez, P.
dc.authorsophosPaniagua, L.
dc.authorsophosBlanco-Teijeiro, M. J.
dc.authorsophosPardo, M.
dc.authorsophosPiñeiro, A.
dc.authorsophosBande
dc.identifier.doi10.3389/fgene.2022.842509
dc.identifier.sophos63389a15250f6f2135360f2b
dc.journal.titleFrontiers in Genetics*
dc.relation.projectIDInstituto de Salud Carlos III [PI16/00143]
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fgene.2022.842509/pdf;https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.842509/pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Coruñaes
dc.subject.keywordCHUACes
dc.subject.keywordFPGMXes
dc.subject.keywordAS Santiagoes
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo de Revisiónes
dc.volume.number13


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional